Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: Incremental value compared with clinical and biochemical markers

Journal of the American College of Cardiology

Volumn 60, Issue 12, 2012, Pages 1067-1076

  Buss, Sebastian J ^a   Emami, Mostafa ^a   Mereles, Derliz ^a   Korosoglou, Grigorios ^a   Kristen, Arnt V ^a   Voss, Andreas ^a   Schellberg, Dieter ^a   Zugck, Christian ^a   Galuschky, Christian ^b   Giannitsis, Evangelos ^a   Hegenbart, Ute ^a   Ho, Anthony D ^a   Katus, Hugo A ^a   Schonland, Stefan O ^a   Hardt, Stefan E ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b TOMTEC IMAGING SYSTEMS GMBH   (Germany)

Author keywords

amyloidosis; biomarker; echocardiography; left ventricular function; prognosis; tissue Doppler; two dimensional strain imaging

Indexed keywords

BIOLOGICAL MARKER; DEXAMETHASONE; IMMUNOGLOBULIN LIGHT CHAIN; MELPHALAN; TROPONIN T;

ADULT; AGE; AMYLOIDOSIS; ARTICLE; COHORT ANALYSIS; DIASTOLIC DYSFUNCTION; DOPPLER ECHOCARDIOGRAPHY; DRUG MEGADOSE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART TRANSPLANTATION; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL RATE; TISSUE DOPPLER IMAGING; TWO DIMENSIONAL ECHOCARDIOGRAPHY; TWO DIMENSIONAL GLOBAL LONGITUDINAL STRAIN;

AGED; AMYLOIDOSIS; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SURVIVAL RATE; TROPONIN T; VENTRICULAR FUNCTION, LEFT;

EID: 84866078444     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.04.043     Document Type: Article

References (51)

1. M.A. Gertz Immunoglobulin light chain amyloidosis: 2011 update on diagnosis, risk-stratification, and management Am J Hematol 86 2011 180 186
2. R.H. Falk, R.L. Comenzo, M. Skinner The systemic amyloidoses N Engl J Med 337 1997 898 909 (Pubitemid 27408573)
3. G. Merlini, V. Bellotti Molecular mechanisms of amyloidosis N Engl J Med 349 2003 583 596 (Pubitemid 36951371)
4. M.A. Gertz, P.R. Greipp, R.A. Kyle Classification of amyloidosis by the detection of clonal excess of plasma cells in the bone marrow J Lab Clin Med 118 1991 33 39
5. J.D. Sipe, M.D. Benson, J.N. Buxbaum Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis Amyloid 17 2010 101 104
6. J.B. Selvanayagam, P.N. Hawkins, B. Paul, S.G. Myerson, S. Neubauer Evaluation and management of the cardiac amyloidosis J Am Coll Cardiol 50 2007 2101 2110 (Pubitemid 350117349)
7. A.V. Kristen, J.B. Perz, S.O. Schonland Non-invasive predictors of survival in cardiac amyloidosis Eur J Heart Fail 9 2007 617 624 (Pubitemid 46702816)
8. A. Dispenzieri, M.A. Gertz, R.A. Kyle Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis J Clin Oncol 22 2004 3751 3757 (Pubitemid 41095215)
9. A.V. Kristen, E. Giannitsis, S. Lehrke Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin T assay Blood 116 2010 2455 2461
10. G. Palladini, C. Campana, C. Klersy Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis Circulation 107 2003 2440 2445 (Pubitemid 36605226)
11. J. Gorcsan III, H. Tanaka Echocardiographic assessment of myocardial strain J Am Coll Cardiol 58 2011 1401 1413
12. T.P. Abraham, V.L. Dimaano, H.Y. Liang Role of tissue Doppler and strain echocardiography in current clinical practice Circulation 116 2007 2597 2609 (Pubitemid 350179223)
13. D. Bellavia, T.P. Abraham, P.A. Pellikka Detection of left ventricular systolic dysfunction in cardiac amyloidosis with strain rate echocardiography J Am Soc Echocardiogr 20 2007 1194 1202 (Pubitemid 47496097)
14. D. Bellavia, P.A. Pellikka, T.P. Abraham Evidence of impaired left ventricular systolic function by Doppler myocardial imaging in patients with systemic amyloidosis and no evidence of cardiac involvement by standard two-dimensional and Doppler echocardiography Am J Cardiol 101 2008 1039 1045
15. J. Koyama, P.A. Ray-Sequin, R.H. Falk Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis Circulation 107 2003 2446 2452 (Pubitemid 36605227)
16. D. Bellavia, P.A. Pellikka, G.B. AL-Zahrani Independent predictors of survival in primary systemic (AL) amyloidosis, including cardiac biomarkers and left ventricular strain imaging: an observational cohort study J Am Soc Echocardiogr 23 2010 643 652
17. J. Koyama, R.H. Falk Prognostic significance of strain Doppler imaging in light-chain amyloidosis J Am Coll Cardiol Img 3 2010 333 342
18. T. Stanton, R. Leano, T.H. Marwick Prediction of all-cause mortality from global longitudinal speckle strain: comparison with ejection fraction and wall motion scoring Circ Cardiovasc Imaging 2 2009 356 364
19. G.Y. Cho, T.H. Marwick, H.S. Kim, M.K. Kim, K.S. Hong, D.J. Oh Global 2-dimensional strain as a new prognosticator in patients with heart failure J Am Coll Cardiol 54 2009 618 624
20. S.J. Buss, D. Wolf, G. Korosoglou Myocardial left ventricular dysfunction in patients with systemic lupus erythematosus: new insights from tissue Doppler and strain imaging J Rheumatol 37 2010 79 86
21. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172 discussion 207-12 (Pubitemid 351193639)
22. A. Dispenzieri, M.Q. Lacy, J.A. Katzmann Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation Blood 107 2006 3378 3383
23. D.C. Seldin, J.J. Anderson, V. Sanchorawala Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation Blood 104 2004 1888 1893 (Pubitemid 39202302)
24. M. Skinner, V. Sanchorawala, D.C. Seldin High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study Ann Intern Med 140 2004 85 93
25. A.V. Kristen, F.U. Sack, S.O. Schonland Staged heart transplantation and chemotherapy as a treatment option in patients with severe cardiac light-chain amyloidosis Eur J Heart Fail 11 2009 1014 1020
26. J.G. Dumesnil, R.M. Shoucri, J.L. Laurenceau, J. Turcot A mathematical model of the dynamic geometry of the intact left ventricle and its application to clinical data Circulation 59 1979 1024 1034 (Pubitemid 9163962)
27. M. Carlsson, M. Ugander, H. Mosen, T. Buhre, H. Arheden Atrioventricular plane displacement is the major contributor to left ventricular pumping in healthy adults, athletes, and patients with dilated cardiomyopathy Am J Physiol Heart Circ Physiol 292 2007 H1452 H1459
28. M.J. Kocica, A.F. Corno, F. Carreras-Costa The helical ventricular myocardial band: global, three-dimensional, functional architecture of the ventricular myocardium Eur J Cardiothorac Surg 29 Suppl 1 2006 S21 S40
29. H. Vogelsberg, H. Mahrholdt, C.C. Deluigi Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy J Am Coll Cardiol 51 2008 1022 1030 (Pubitemid 351318125)
30. P. Pibarot, J.G. Dumesnil Longitudinal myocardial shortening in aortic stenosis: ready for prime time after 30 years of research? Heart 96 2009 95 96
31. S. Herrmann, S. Stork, M. Niemann Low-gradient aortic valve stenosis myocardial fibrosis and its influence on function and outcome J Am Coll Cardiol 58 2011 402 412
32. P. Pibarot, J.G. Dumesnil Paradoxical low-flow, low-gradient aortic stenosis adding new pieces to the puzzle J Am Coll Cardiol 58 2011 413 415
33. Y. Mizuguchi, Y. Oishi, H. Miyoshi, A. Iuchi, N. Nagase, T. Oki The functional role of longitudinal, circumferential, and radial myocardial deformation for regulating the early impairment of left ventricular contraction and relaxation in patients with cardiovascular risk factors: a study with two-dimensional strain imaging J Am Soc Echocardiogr 21 2008 1138 1144
34. C.L. Hung, A. Verma, H. Uno Longitudinal and circumferential strain rate, left ventricular remodeling, and prognosis after myocardial infarction J Am Coll Cardiol 56 2010 1812 1822
35. H. Geyer, G. Caracciolo, H. Abe Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications J Am Soc Echocardiogr 23 2010 351 369 quiz 453-5
36. L.P. Koopman, C. Slorach, C. Manlhiot Assessment of myocardial deformation in children using Digital Imaging and Communications in Medicine (DICOM) data and vendor independent speckle tracking software J Am Soc Echocardiogr 24 2011 37 44
37. S.J. Buss, D. Mereles, M. Emami Rapid assessment of longitudinal systolic left ventricular function using speckle tracking of the mitral annulus Clin Res Cardiol 101 2012 273 280
38. W. Hosch, A.V. Kristen, M. Libicher Late enhancement in cardiac amyloidosis: correlation of MRI enhancement pattern with histopathological findings Amyloid 15 2008 196 204
39. S. Lehrke, H. Steen, A.V. Kristen Serum levels of NT-proBNP as surrogate for cardiac amyloid burden: new evidence from gadolinium-enhanced cardiac magnetic resonance imaging in patients with amyloidosis Amyloid 16 2009 187 195
40. B.A. Austin, W.H. Tang, E.R. Rodriguez Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis J Am Coll Cardiol Img 2 2009 1369 1377
41. D. Cramariuc, G. Cioffi, A.E. Rieck Low-flow aortic stenosis in asymptomatic patients: valvular-arterial impedance and systolic function from the SEAS Substudy J Am Coll Cardiol Img 2 2009 390 399
42. G. Takemura, Y. Takatsu, K. Doyama Expression of atrial and brain natriuretic peptides and their genes in hearts of patients with cardiac amyloidosis J Am Coll Cardiol 31 1998 754 765
43. M. Nordlinger, B. Magnani, M. Skinner, R.H. Falk Is elevated plasma B-natriuretic peptide in amyloidosis simply a function of the presence of heart failure? Am J Cardiol 96 2005 982 984 (Pubitemid 41362524)
44. A. Dispenzieri, M.A. Gertz, R.A. Kyle Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation Blood 104 2004 1881 1887 (Pubitemid 39202301)
45. T. Bochtler, U. Hegenbart, C. Heiss Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis Haematologica 93 2008 459 462 (Pubitemid 351398651)
46. S. Dietrich, S.O. Schonland, A. Benner Treatment with intravenous melphalan and dexamethasone is not able to overcome the poor prognosis of patients with newly diagnosed systemic light chain amyloidosis and severe cardiac involvement Blood 116 2010 522 528
47. T. Coelho, L.F. Maia, A. da Silva Martins Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial Neurology 79 2012 785 792
48. L.M. Dember, P.N. Hawkins, B.P. Hazenberg Eprodisate for the treatment of renal disease in AA amyloidosis N Engl J Med 356 2007 2349 2360 (Pubitemid 46883769)
49. J.D. Gillmore, G.A. Tennent, W.L. Hutchinson Sustained pharmacological depletion of serum amyloid P component in patients with systemic amyloidosis Br J Haematol 148 2010 760 767
50. M. Miyata, T. Sato, M. Kugimiya The crystal structure of the green tea polyphenol (-)-epigallocatechin gallate-transthyretin complex reveals a novel binding site distinct from the thyroxine binding site Biochemistry 49 2010 6104 6114
51. D. Mereles, S.J. Buss, S.E. Hardt, W. Hunstein, H.A. Katus Effects of the main green tea polyphenol epigallocatechin-3-gallate on cardiac involvement in patients with AL amyloidosis Clin Res Cardiol 99 2010 483 490